Ferric Carboxymaltose

Ferric carboxymaltose, a novel iron replacement therapy, stands out with its distinctive scientific and chemical attributes. Unlike traditional iron supplements, its carbohydrate-based structure, featuring iron(III) ions, imparts a neutral taste and odor, making it more tolerable for patients. Unlike hygroscopic iron salts, its stable formulation ensures a convenient injectable form. Chemically, ferric carboxymaltose is a complex molecule composed of a ferric ion core surrounded by a carboxymaltose shell. The carboxymaltose ligands, linked to the ferric ions through ester bonds, create a stable, biocompatible complex. This unique structure enables a gradual, controlled release of iron into the bloodstream, minimizing adverse effects. Ferric carboxymaltoses scientific properties and pleasant sensory qualities make it a valuable therapeutic option for iron deficiency anemia. WBCIL, a renowned API manufacturer, adheres to stringent quality standards (CGMP and ISO certified), ensuring every batch of Ferric Carboxymaltose meets the highest purity, potency, and safety benchmarks. Our extensive experience dating back to 1962 guarantees consistent, reliable products that exceed industry expectations. 

USP of Ferric Carboxymaltose:-

• IV delivery: Bypasses digestion, rapid absorption, reduced GI side effects.
• Ideal: For oral iron intolerance/resistance or CKD.
• Carbohydrate shell: Controlled iron release, reduces overload risk.
• Shorter infusion: Improves treatment time, reduces infusion reaction risk.
• Safety: Low incidence of severe allergic reactions.

Applications of Ferric Carboxymaltose:-

• Iron Deficiency Anemia: Primary treatment for restoring hemoglobin levels.
• Chronic Kidney Disease: Manages anemia in renal patients.
• Rapid Replenishment: Offers quick iron restoration in acute deficiencies.
• Postpartum Care: Aids new mothers in recovering iron levels swiftly.
• Chronic Heart Failure: Addresses iron deficiency, improving patient outcomes.
• Inflammatory Bowel Disease: Combats anemia in IBD patients. 

FAQs of FERRIC CARBOXYMALTOSE: